LIPID NANOSYSTEM FOR PACLITAXEL AND ALPHA MANGOSTIN: ADDRESSING DRUG RESISTANCE AND NEPHROTOXICITY ASSOCIATED WITH OVARIAN CANCER CHEMOTHERAPY
Ph.D
Saved in:
Main Author: | SANTWANA K C |
---|---|
Other Authors: | PHARMACY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/234639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Design and manufacture of dry reconstitute alpha-mangostin liposomal powder by novel freeze-drying at room temperature
by: Ruthairat Benjakul
Published: (2023) -
Lipid-dendrimer hybrid nanosystems for the delivery of anti-cancer drug combinations
by: DONG JINGHUA
Published: (2018) -
Reactive oxygen species-scavenging nanosystems in the treatment of diabetic wounds
by: Xiong, Yuan, et al.
Published: (2023) -
Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
by: Chaudhury, A., et al.
Published: (2014) -
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
by: Lee, Matilda X, et al.
Published: (2021)